![](/media/vdqhqzem/salmon.png)
Uppsala Reports editor
@UMCGlobalSafety
In focus / 07 June 2024
Medication errors account for the bulk of adverse events to medicines. How do they occur, how do we ensure they are reported if they do occur, and how may we prevent them?
Medication errors due to look-alike medicines, unclear communication, and distractions during administration, may occur for many different reasons. In this episode, Ghita Benabdallah and Loubna Alj from the national pharmacovigilance centre of Morocco, and Alem Zekarias from Uppsala Monitoring Centre, discuss medication errors in the pharmacovigilance context – how they occur, how we can prevent them from occurring and, when they do occur, make sure that they are reported as such.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
The introduction of new medications for HIV and TB in Namibia required a more proactive hand in monitoring their safety. For the Namibian TWG, active surveillance was the answer.
In focus / 23 October 2023
Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?
In focus / 02 April 2024
Our genes contribute anything from 15 to 95% of how we react to medicines. Why is this the case, and when is genetic testing necessary to avoid the risk of potential side effects?
In focus / 21 August 2024